{"id":"https://openalex.org/W2080040198","doi":"https://doi.org/10.1097/00000421-198704000-00045","title":"High-Dose Chemotherapy Concepts and Strategies","display_name":"High-Dose Chemotherapy Concepts and Strategies","publication_year":1987,"publication_date":"1987-04-01","ids":{"openalex":"https://openalex.org/W2080040198","doi":"https://doi.org/10.1097/00000421-198704000-00045","mag":"2080040198","pmid":"https://pubmed.ncbi.nlm.nih.gov/3551575"},"language":"en","primary_location":{"id":"doi:10.1097/00000421-198704000-00045","doi":"https://doi.org/10.1097/00000421-198704000-00045","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00000421-198704000-00045","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006242958","display_name":"Marcel Odaimi","orcid":"https://orcid.org/0009-0002-6021-0360","observed_orcids":["https://orcid.org/0009-0002-6021-0360","https://orcid.org/0000-0002-3244-1957"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcel Odaimi","raw_affiliation_strings":["the Department of Medical Oncology, Division of Medical Services, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Medical Oncology, Division of Medical Services, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044064524","display_name":"Jaffer A. Ajani","orcid":"https://orcid.org/0000-0001-9946-0629","observed_orcids":["https://orcid.org/0000-0001-9946-0629"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaffer Ajani","raw_affiliation_strings":["the Department of Medical Oncology, Division of Medical Services, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas","GI Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Medical Oncology, Division of Medical Services, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"GI Medical Oncology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.5509,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.64587865,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"10","issue":"2","first_page":"123","last_page":"132"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.28220000863075256,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.28220000863075256,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.14880000054836273,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.057999998331069946,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":1.0},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.6700000166893005},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9660000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6650000214576721},{"id":"https://openalex.org/keywords/regional-chemotherapy","display_name":"regional chemotherapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/autologous-bone-marrow-transplantation","display_name":"autologous bone marrow transplantation","score":0.9419999718666077},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9750000238418579},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7639999985694885},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8240000009536743},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.753000020980835},{"id":"https://openalex.org/keywords/small-cell-carcinoma","display_name":"small cell carcinoma","score":0.9110000133514404},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8931829929351807},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6815881133079529},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6503115892410278},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5303412675857544},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.4979560375213623},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4955509901046753},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4727120101451874},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.453428715467453},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.42990708351135254},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39386168122291565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2861468493938446}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00000421-198704000-00045","doi":"https://doi.org/10.1097/00000421-198704000-00045","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00000421-198704000-00045","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:3551575","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3551575","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2104184942","https://openalex.org/W22139211","https://openalex.org/W2055673734","https://openalex.org/W1573033164","https://openalex.org/W2083616014","https://openalex.org/W2052618009","https://openalex.org/W2148334575","https://openalex.org/W2144362317","https://openalex.org/W4246054895","https://openalex.org/W2181881700"],"abstract_inverted_index":{"In":[0,13,76],"experimental":[1],"tumors,":[2],"a":[3,117,153],"steep":[4],"dose-response":[5],"curve":[6],"has":[7,111,130],"been":[8,94],"demonstrated":[9],"for":[10],"chemosensitive":[11],"malignancies.":[12],"clinical":[14,226],"practice,":[15],"increasing":[16,78,86],"dose":[17,21,80],"over":[18],"the":[19,79,114,124,141,158,187],"conventional":[20,175],"results":[22],"in":[23,34,53,113,132,157,217,225],"higher":[24,35],"responses.":[25],"These":[26],"observations":[27],"have":[28,93],"prompted":[29],"efforts":[30],"to":[31,41,85,89,186],"use":[32,44,189],"chemotherapy":[33,129],"doses.":[36],"Initial":[37],"empiricism":[38],"lends":[39],"itself":[40],"more":[42],"rational":[43],"of":[45,81,108,116,120,143,151,160,190],"high-dose":[46,57,64,128,191],"chemotherapy.":[47,192],"Strategies":[48],"are":[49,237],"based":[50],"on":[51,140],"alteration":[52],"drug":[54,71,196,210,213],"schedules":[55],"[e.g.,":[56,63],"cytosine":[58],"arabinoside":[59],"(Ara-C)],":[60],"drug-to-drug":[61],"interaction":[62],"methotrexate":[65],"(MTX)":[66],"with":[67,169],"citrovorum":[68],"rescue],":[69],"and":[70,110,136,165,181,200,231,241],"pharmacokinetics":[72],"(e.g.,":[73,163],"regional":[74],"chemotherapy).":[75],"general,":[77],"cytotoxic":[82],"agents":[83],"leads":[84],"toxicity.":[87,122],"Methods":[88],"circumvent":[90],"unacceptable":[91],"toxicity":[92],"explored.":[95],"Autologous":[96],"bone":[97],"marrow":[98],"transplant":[99],"is":[100,198,209],"one":[101,201],"such":[102,152],"method":[103],"that":[104,195,203],"provides":[105],"new":[106,118],"avenues":[107],"therapy":[109],"resulted":[112,131],"emergence":[115],"spectrum":[119],"dose-limiting":[121],"Despite":[123],"improved":[125],"response":[126,134],"rate,":[127],"short":[133],"durations":[135],"no":[137],"significant":[138],"impact":[139],"survival":[142],"cancer":[144],"patients":[145],"as":[146,183],"yet.":[147],"The":[148,212],"greater":[149],"benefit":[150],"modality":[154],"may":[155],"be":[156,205],"consolidation":[159],"drug-sensitive":[161],"tumors":[162],"lymphoma":[164],"small":[166],"cell":[167],"carcinoma)":[168],"minimal":[170,174],"residual":[171],"disease":[172],"after":[173],"therapy.":[176],"We":[177,193],"review":[178],"various":[179],"factors":[180,236],"concepts":[182],"they":[184],"relate":[185],"current":[188],"conclude":[194],"resistance":[197],"multifactorial,":[199],"variable":[202],"can":[204],"manipulated":[206],"by":[207],"clinicians":[208],"dose.":[211],"concentration":[214],"appears":[215],"crucial":[216],"enhancing":[218],"cytotoxicity.":[219],"All":[220],"frontiers":[221],"examining":[222],"this":[223],"approach":[224],"practice":[227],"deserve":[228],"continued":[229],"enthusiasm":[230],"cautious":[232],"exploration":[233],"while":[234],"other":[235],"being":[238],"fully":[239],"understood":[240],"exploited.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}